Local Manufacturing Incentives Accelerate – New Investment Facilities Open Doors for Equipment and Technology Suppliers

Africa's push for local manufacturing of health products is accelerating in 2026, creating significant new opportunities for suppliers of production equipment, testing instruments, and related technologies.

Major Investment Facilities Now Active

The World Bank launched the Africa Initiative for Medical Access and Manufacturing (AIM2030) in May 2026, aimed at mobilizing investment, boosting innovation, and encouraging south-south exchange on access to medicines. The initiative focuses on strengthening physical infrastructure, building human capital, and mobilizing the private sector through blended finance to scale local manufacturing across Africa.

The European Investment Bank and Nigeria's Bank of Industry concluded a EUR 50 million agreement in March 2026 to boost healthcare manufacturing projects in Nigeria, delivered through a credit line supporting local manufacturers of pharmaceuticals, vaccines, and diagnostics.

Gavi's African Vaccine Manufacturing Accelerator is expected to make its first cash disbursement to an African vaccine manufacturer in the second half of 2026, with Gavi proposing 

an additional US$189 million investment to further develop Africa's vaccine manufacturing sector.

Technology Transfer Gains Momentum

Africa CDC and Aspen Pharmacare are in advanced discussions on a long-term demand and supply alignment framework aimed at strengthening sustainable vaccine manufacturing in Africa. The proposed collaboration explores a multi-year framework focused on strengthening local manufacturing capacity and supply security, with the potential to reach tens to hundreds of millions of doses annually over time.

Biovac and Proparco announced a US$180 million investment collaboration to support the expansion of a multi-vaccine manufacturing facility, including technology transfer.

What This Means for Equipment Suppliers

As local manufacturing capacity expands, so does demand for the equipment and inputs required to build it. Pharmaceutical and biological production requires bioreactors, purification systems, fill-finish equipment, quality control laboratories, and cold-chain infrastructure. Medical device assembly requires injection molding machines, sterilization equipment, and testing instruments.

Kenya's export processing zones offer a "ten-year tax holiday" – full exemption from corporate income tax for the first 10 years, with the rate locked at 25% for the subsequent decade. Egypt's "Golden License" scheme allows factories to bypass bureaucratic hurdles with a single approval. These incentives make local production increasingly attractive for both African and foreign investors.

The opportunity for Chinese equipment manufacturers is substantial. The challenge lies in identifying the right partners and navigating the regulatory and logistical complexities of supplying into African manufacturing projects. A one-stop foreign trade service provider with experience in both equipment export and African market entry can bridge this gap effectively.